Mark Robert Litzow

161PUBLICATIONS
540CO-AUTHORS
Haematological tumoursGene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (161)

|Aug 31, 2026
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

|Aug 23, 2026
Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents.

|Jul 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AML.

|Jul 25, 2026
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients.

|Jul 18, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.

|Feb 18, 2026
CRLF2 rearrangement and extramedullary disease in B-cell acute lymphoblastic leukemia: a possible link?

Flavia Gava, Bonnie Yates, Zhouxin Sun

Pageof 27

Frequent Collaborators

56 joint publications

Mrinal S Patnaik

41 joint publications

Mithun Vinod Shah

38 joint publications

Naseema Gangat

35 joint publications

William Joseph Hogan